Company: SPEG
Filing Date: 2025-07-15
Form Type: 424B4
Source: 0001213900-25-064326
Chunk: 181

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-07-15
Form: 424B4
Chunk 181
---
. Mr.Eisenberg is an attorney with practice areas in finance law and corporate governance. Mr.Eisenberg also has extensive experience as a private markets investor. He currently serves on the Board of Directors of NASDAQ -listedbiotechnology company AbPro Corporation (“ AbPro” — Nasdaq: ABP), where he has chaired both the Audit and Compensation Committees since November 2024. AbPro had merged with Atlantic Coastal Acquisition II, a NASDAQ -listedSPAC (“ ACAB”), where from 2021 through 2024, Mr.Eisenberg served as a Director and Chief Strategy Officer. From March 2021 Mr.Eisenberg served as a Director and Chief Strategy Officer of Atlantic Coastal Acquisition Corp. (“ ACAH”), a NASDAQ -listedSPAC that raised $330million, until September 2023, when he resigned in connection with a sponsor handover. In 2020, Mr.Eisenberg became a founding partner in Palo Santo VC, a $50million venture capital firm specializing in innovative mental health treatments. Mr.Eisenberg leads Tappan Street, a family office where he focuses on investments in sports and entertainment media rights and other private investments. M. Eisenberg has also served as an advisor of the Bambu Fund LLC, a mental health venture capital fund, from 2019 to 2024. Mr.Eisenberg holds a JD from the University of Michigan an MBA from Georgetown University, as well as an undergraduate degree with honors from the University of Miami. Mr.Eisenberg is a member of the Bar of the State of New York. Mr.Eisenberg began his career in politics working in the Office of U.S. Senator Debbie Stabenow, Patton Boggs and the D.C. based research group Marwood Group, prior to his principal investing career, which began at the hedge fund Christofferson Robb & Company. Past performance of our management team or their affiliates is not a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able to identify a suitable candidate for our initial business combination. You should not rely on the historical performance record of our management team or their affiliates as indicative of our future performance. Our officers and directors may have conflicts of interest with other entities to which they owe fiduciary or contractual obligations with respect to initial business combination opportunities. For a list of our officers and directors and entities for which a conflict of interest may or does exist between such persons and us, as well